The world of pharmaceuticals is full of intense competition and exciting advances, but the balance sheets of the big industry players don’t always fully reflect that reality. It’s common for companies to coast along on the strength of past, lucrative accomplishments, with newer drugs and treatments accounting for a very small piece of their yearly earnings. Industry examiners, however, tend not to be as concerned with what companies once did. Instead, in the eternal effort to figure out who is doing the most that is new and exciting, they might turn to the “Freshness Index.” Curious about what this index.. READ MORE »
